APO 014 Pill - orange & white capsule/oblong, 11mm
Pill with imprint APO 014 is Orange & White, Capsule/Oblong and has been identified as Dilt-XR diltiazem extended-release 120 mg. It is supplied by Apotex Corp.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Angina Pectoris Prophylaxis; Heart Failure; High Blood Pressure and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem diltiazem extended-release 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO 014
Dilt-XR
- Imprint
- APO 014
- Strength
- diltiazem extended-release 120 mg
- Color
- Orange & White
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-0014 | Apotex Corp. |
| 33358-0109 (Discontinued) | CorePharma, LLC (repackager) |
| 54868-3103 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "APO 014"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (186)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
- Diltiazem drug information
- Diltiazem (Intravenous) (Advanced Reading)
- Diltiazem Long-Acting Capsules
- Diltiazem Long-Acting Tablets
- Diltiazem 12-Hour Sustained-Release Capsules
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +7 more
Professional resources
- DilTIAZem monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
